"During the first few years that followed Yondelis®’s approval in ovarian cancer, Austria was selling more, in terms of volume of units, than the UK."
In Conversation
"At Sanofi Genzyme, we do not see our activities as mere transactions, but an investment in working with the healthcare systems and patients within Canada."
"The vision has always been to develop Vienna as a research stronghold, not just within Austria, but across the entire central European region."
"Intracrinology is a newly established field within women’s health. There is definitely a huge and pressing unmet medical need here. To give an indication, in the…
There is no country that can manage without Indian medicines. Every developed country has an aging population and as their budgets are shrinking, affordable quality products…
"As long as we have the patients' consent and give support and not promotion, a medical device company is able to contact patients. This is of…
"The government and companies present in Austria are able to leverage upon the high education levels of the Austrian population. It has implications in terms of…
"Latin America in general and Brazil in particular undoubtedly hold a huge development potential in the dermatology field."
"Following the path carved by my predecessor, I have made it a point to increase our responsiveness."
"Celerion in Europe is currently diversifying the scope of services it can provide in terms of field of research and this will kick start further growth…
"Bulgaria and Germany have a strong relationship that stems from the two countries’ long history together."
"As a result of cultural similarities and the German chamber’s role facilitating business, many German companies decide to use Austria as a hub for their activities…
